Efficacy of Quetiapine for Pediatric Delirium
Phase of Trial: Phase I/II
Latest Information Update: 18 Dec 2017
Price : $35 *
At a glance
- Drugs Quetiapine (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 27 Dec 2016 Status changed from active, no longer recruiting to discontinued.
- 31 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Dec 2015 Planned end date changed from 1 Dec 2016 to 1 Dec 2017, as reported by ClinicalTrials.gov.